BDSX 8-K/A 2026-01-12

BIODESIX INC (BDSX) 8-K/A dated 2026-01-12 — accession 0001193125-26-010114. This URL is the filing, not the BDSX hub.

BIODESIX INC (BDSX) is a diagnostics & research company listed on NASDAQ.

BIODESIX INC filed a 8-K/A on 2026-01-12. Accession 0001193125-26-010114.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BDSX revenue for 2025-12-31 was $88.5M. Net income was -$35.3M. Revenue was up 24.1% from 2024-12-31 to 2025-12-31. BDSX currently screens at market cap $157.6M.

Not investment advice. The BDSX SEC hub lists recent forms. The stock page is the research view.